For instance, it has been observed that PD-1 receptor inhibition selectively enhanced functionality and anti-tumour efficacy of low affinity HER2-28Z CAR-T cells in ovarian cancer, reducing the immunosuppressive potential of the TME (102). Here, ERBB2 is linked to neoplasm.